captopril has been researched along with Liver Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 5 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Z; Liao, N; Liu, X; Wang, P; Wang, Y; Zeng, Y; Zhang, D; Zhao, B; Zhao, Q; Zheng, Y; Zhuang, Q | 1 |
| Christophi, C; Fifis, T; Gordon, CL; Kastrappis, G; Muralidharan, V; Perini, MV; Riddiough, GE; Tran, BM; Vincan, E; Walsh, KA | 1 |
| Arora, G; Bandiera, S; Barrett, SC; Baumert, TF; Chung, RT; Crouchet, E; Del Zompo, F; Durand, SC; El Saghire, H; Felli, E; Fuchs, BC; Fujiwara, N; Ghoshal, S; Giannone, F; Hoshida, Y; Li, S; Lupberger, J; Oudot, MA; Pessaux, P; Pochet, N; Ponsolles, C; Qian, T; Rasha, FA; Schaeffer, E; Schuster, C; Slovic, N; Sojoodi, M; Tanabe, KK; Van Renne, N; Zhu, S | 1 |
| Christophi, C; Fifis, T; Kastrappis, G; Paolini, R; Perini, MV; Vallejo Ardila, DL; Walsh, KA | 1 |
| Diz-Muñoz, A; Freire Valls, A; Imle, A; Liang, J; Lu, J; Muley, T; Radhakrishnan, P; Ruiz de Almodovar, C; Salfenmoser, M; Schleussner, N; Schmidt, T; Schneider, M; Shen, Y; Wang, G; Wang, X; Wirsik, NM | 1 |
| Chen, IS; Chou, CT; Hao, LJ; Jan, CR; Kuo, CC; Liang, WZ; Liu, YY; Wang, JL | 1 |
| Ager, EI; Christophi, C; Neo, J; Wen, SW | 1 |
| Ager, EI; Christophi, C; Costa, PL; Koh, SL; Malcontenti-Wilson, C; Muralidharan, V | 1 |
| Batsalova, T; Dzhambazov, B; Klaczkowska, D; Kostova, Z; Teneva, I | 1 |
| Christophi, C; Malcontenti-Wilson, C; Muralidharan, V; Neo, JH | 1 |
10 other study(ies) available for captopril and Liver Neoplasms
| Article | Year |
|---|---|
Remodeling Tumor-Associated Neutrophils to Enhance Dendritic Cell-Based HCC Neoantigen Nano-Vaccine Efficiency.
Topics: Animals; Captopril; Carcinoma, Hepatocellular; Dendritic Cells; Ferric Compounds; Liver Neoplasms; Mice; Neutrophils; Tumor Microenvironment | 2022 |
Captopril, a Renin-Angiotensin System Inhibitor, Attenuates Tumour Progression in the Regenerating Liver Following Partial Hepatectomy.
Topics: Animals; Antihypertensive Agents; Captopril; Colorectal Neoplasms; Enzyme Inhibitors; Hepatectomy; Humans; Liver Neoplasms; Mice; Neoplasm Recurrence, Local; Programmed Cell Death 1 Receptor; Renin-Angiotensin System; Tumor Microenvironment | 2022 |
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carcinogenesis; Carcinoma, Hepatocellular; Chemoprevention; Disease Progression; ErbB Receptors; Liver Cirrhosis; Liver Neoplasms; Peptidyl-Dipeptidase A; Rats; Transcriptional Activation | 2022 |
Immunomodulatory effects of renin-angiotensin system inhibitors on T lymphocytes in mice with colorectal liver metastases.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carcinoma; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; Humans; Liver Neoplasms; Lymphocytes, Tumor-Infiltrating; Male; Mice; Renin-Angiotensin System; T-Lymphocytes | 2020 |
Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer.
Topics: Angiogenesis Inhibitors; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bevacizumab; Cancer-Associated Fibroblasts; Captopril; Colorectal Neoplasms; Drug Synergism; Humans; Liver Neoplasms; Losartan; Lung Neoplasms; Neovascularization, Pathologic; Renin-Angiotensin System; Tumor Microenvironment | 2020 |
Effect of Captopril on Ca²⁺ Homeostasis and Cell Viability in Human Hepatoma Cells.
Topics: Apoptosis; Calcium; Calcium Signaling; Captopril; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Homeostasis; Humans; Liver Neoplasms; Type C Phospholipases | 2018 |
The renin angiotensin system regulates Kupffer cells in colorectal liver metastases.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Colorectal Neoplasms; Disease Models, Animal; Gadolinium; Kupffer Cells; Liver Neoplasms; Macrophages; Male; Mice; Mice, Inbred CBA; Peptide Fragments; Renin-Angiotensin System | 2013 |
Blockade of the renin-angiotensin system inhibits growth of colorectal cancer liver metastases in the regenerating liver.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Captopril; Cell Proliferation; Colorectal Neoplasms; Immunoenzyme Techniques; Liver Neoplasms; Liver Regeneration; Male; Mice; Mice, Inbred CBA; Neovascularization, Pathologic; Real-Time Polymerase Chain Reaction; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Burden; Tumor Cells, Cultured | 2014 |
Influence of captopril on the cellular uptake and toxic potential of microcystin-LR in non-hepatic adhesive cell lines.
Topics: Adenocarcinoma; Amnion; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cell Adhesion; Cell Line; Drug Interactions; Humans; Liver Neoplasms; Lung Neoplasms; Marine Toxins; Membrane Transport Proteins; Microcystins | 2016 |
Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Captopril; Colorectal Neoplasms; Disease Models, Animal; Irbesartan; Liver Neoplasms; Male; Mice; Mice, Inbred CBA; Microscopy, Electron, Scanning; Necrosis; Tetrazoles | 2007 |